O'Brien A, Clapp L, Singer M (2002). «Terlipressin for norepinephrine-resistant septic shock». Lancet. 359 (9313): 1209–10. PMID11955542. doi:10.1016/S0140-6736(02)08225-9 !CS1 manut: Nomes múltiplos: lista de autores (link)
Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). «Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome». J Hepatol. 33 (1): 43–8. PMID10905585. doi:10.1016/S0168-8278(00)80158-0 !CS1 manut: Nomes múltiplos: lista de autores (link)
nih.gov
ncbi.nlm.nih.gov
O'Brien A, Clapp L, Singer M (2002). «Terlipressin for norepinephrine-resistant septic shock». Lancet. 359 (9313): 1209–10. PMID11955542. doi:10.1016/S0140-6736(02)08225-9 !CS1 manut: Nomes múltiplos: lista de autores (link)
Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). «Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome». J Hepatol. 33 (1): 43–8. PMID10905585. doi:10.1016/S0168-8278(00)80158-0 !CS1 manut: Nomes múltiplos: lista de autores (link)
Saner FH, Canbay A, Gerken G, Broelsch CE. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):207-17. [S.l.: s.n.] PMID19072411
Krag A, Borup T, Møller S, Bendtsen F. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ther. 2008 Nov;25(11):1105-40. [S.l.: s.n.] PMID19018483
Baik SK, Jeong PH, Ji SW, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol. 2005 Mar;100(3):631-5. [S.l.: s.n.] PMID15743362
Abid S, Jafri W, Hamid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial. Am J Gastroenterol. 2009 Mar;104(3):617-23. [S.l.: s.n.] PMID19223890
Colle I, Durand F, Pessione F, et al. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol. 2002 Aug;17(8):882-8. [S.l.: s.n.] PMID12164964
Moreau R, Durand F, Poynard T, et el. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002 Apr;122(4):923-30. [S.l.: s.n.] PMID11910344
